We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DNA Analysis Speeds Up Identification of Pathogenic E. coli

By Labmedica staff writers
Posted on 24 Mar 2008
New genetic techniques have enabled scientists to test the DNA of Escherichia coli (E. More...
coli) and to examine very small genetic changes called single nucleotide polymorphisms (SNPs). Using these SNPs, scientists analyzed 96 markers, making genetic analysis of pathogenic bacteria possible at a rate never before accomplished.

E coli produce toxins, called Shiga toxins, which are responsible for illness in infected people. These toxins block protein synthesis, an essential cellular function, particularly in the kidneys. The scientists found that the different clades (groups of organisms from a single ancestor) produced different kinds of Shiga toxins in varying amounts based on their DNA. The individual bacteria could be separated into nine major clades.

The bacteria usually come from animal waste that has contaminated human sources of food or water. Finding out how the bacteria entered the food source always has been a challenge, but now food safety experts can use DNA in the same manner that police use DNA at crime scenes. Scientists will be able to identify those bacteria making people sick, find out where they entered the food source, and use this information to reduce the contamination.

"It used to take three months to score one gene individually,” said Thomas Whittam, Hannah Distinguished Professor at the National Food Safety and Toxicology Center at Michigan State University (NFSTC; East Lansing, MI, USA). "Now, we are working on a new, more rapid system that can do thousands of genes per day.”

In a study reported in the March 2008 issue of the Proceedings of the [U.S.] National Academy of Sciences (PNAS), Prof. Whittam and colleagues examined DNA of more than 500 strains of a particularly dangerous member of the E. coli family, O157:H7. "For the first time, we know why some outbreaks cause serious infections and diseases and others don't,” Prof. Whittam said. "The different E. coli groups produce different toxins. Now, we are working on a new, more rapid system that can do thousands of genes per day.”

Prof. Whittam also has plans to use the methodology to study other bacterial strains, such as Shigella, a major cause of diarrhea around the world. "This new equipment can be used to identify hundreds of thousands of pathogenic bacteria,” he said.


Related Links:
National Food Safety and Toxicology Center at Michigan State University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.